{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:42:54Z","timestamp":1787726574554,"version":"build-2784847793"},"publisher-location":"Cham","reference-count":56,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030219154","type":"print"},{"value":"9783030219161","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/5584_2019_369","type":"book-chapter","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T13:03:22Z","timestamp":1556024602000},"page":"243-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Role of Probiotics in Eradication Therapy for Helicobacter pylori Infection"],"prefix":"10.1007","author":[{"given":"Shigeru","family":"Kamiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"369_CR1","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1111\/j.1572-0241.1998.00600.x","volume":"93","author":"Y Aiba","year":"1998","unstructured":"Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y (1998) Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 93:2097\u20132101. https:\/\/doi.org\/10.1111\/j.1572-0241.1998.00600.x","journal-title":"Am J Gastroenterol"},{"key":"369_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2036.2001.00923.x","volume":"15","author":"A Armuzzi","year":"2001","unstructured":"Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V, Cammarota G, Anti M, De L, Pola P, Gasbarrini G, Gasbarrini A (2001) The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Alimen Pharmacol Ther 15:163\u2013169","journal-title":"Alimen Pharmacol Ther"},{"key":"369_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1128\/IAI.74.1.425-434.2006","volume":"74","author":"GE Bergonzelli","year":"2006","unstructured":"Bergonzelli GE, Granato D, Pridmore RD, Marvin-Guy LF, Donnicola D, Corthesy-Theulaz IE (2006) GroEL of Lactobacillus johnsonii La1 (NCC533) is cell surface associated: potential role in interactions with the host and the gastric pathogen Helicobacter pylori. Infect Immun 74:425\u2013434. https:\/\/doi.org\/10.1128\/IAI.74.1.425-434.2006","journal-title":"Infect Immun"},{"key":"369_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0140-6736(08)60207-X","volume":"371","author":"MG Besselink","year":"2008","unstructured":"Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, Nieuwenhuijs VB, Bollen TL, van Ramshorst B, Witteman BJ, Rosman C, Ploeg RJ, Brink MA, Schaapherder AF, Dejong CH, Wahab PJ, van Laarhoven CJ, van der Harst E, van Eijck CH, Cuesta MA, Akkermans LM, Gooszen HG (2008) Dutch Acute Pancreatitis Study Group: probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371:651\u2013659. https:\/\/doi.org\/10.1016\/S0140-6736(08)60207-X","journal-title":"Lancet"},{"key":"369_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1523-5378.2009.00675.x","volume":"14","author":"S Boonyaritichaikij","year":"2009","unstructured":"Boonyaritichaikij S, Kuwabara K, Nagano J, Kobayashi K, Koga Y (2009) Long-term administration of probiotics to asymptomatic pre-school children for either eradication or the prevention of Helicobacter pylori infection. Helicobacter 14:202\u2013207. https:\/\/doi.org\/10.1111\/j.1523-5378.2009.00675.x","journal-title":"Helicobacter"},{"key":"369_CR6","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1046\/j.1365-2036.2000.00885.x","volume":"14","author":"F Canducci","year":"2000","unstructured":"Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P, Gasbarrini G, Gasbarrini A (2000) A lyophilized inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 14:1625\u20131629","journal-title":"Aliment Pharmacol Ther"},{"key":"369_CR7","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1111\/j.1572-0241.2002.07063.x","volume":"97","author":"F Cremonini","year":"2002","unstructured":"Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, Nista EC, Cammarota G, Gasbarrini G, Gasbarrini A (2002) Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 97:2744\u20132749. https:\/\/doi.org\/10.1111\/j.1572-0241.2002.07063.x","journal-title":"Am J Gastroenterol"},{"key":"369_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","volume":"151","author":"CA Fallone","year":"2016","unstructured":"Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, Jones NL, Render C, Leontiadis GI, Moayyedi P, Marshall JK (2016) The Tronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology 151:51\u201369. https:\/\/doi.org\/10.1053\/j.gastro.2016.04.006","journal-title":"Gastroenterology"},{"key":"369_CR9","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00228-017-2291-6","volume":"73","author":"JR Feng","year":"2017","unstructured":"Feng JR, Wang F, Qiu X, McFarland LV, Chen PF, Zhou R, Liu J, Zhao Q, Li J (2017) Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis. Eur J Clin Pharmacol 73:1199\u20131208. https:\/\/doi.org\/10.1007\/s00228-017-2291-6","journal-title":"Eur J Clin Pharmacol"},{"key":"369_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00042737-200101000-00005","volume":"13","author":"CP Felley","year":"2001","unstructured":"Felley CP, Corthesy-Theulaz I, Rivero JL, Sipponen P, Kaufmann M, Bauerfeind P, Wiesel PH, Brassart D, Pfeifer A, Blum AL, Michetti P (2001) Favourable effect of an acididied mild (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 13:25\u201329","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"369_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1128\/CVI.13.2.219-226.2006","volume":"13","author":"CM Galdeano","year":"2006","unstructured":"Galdeano CM, Perdigon G (2006) The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol 13:219\u2013226. https:\/\/doi.org\/10.1128\/CVI.13.2.219-226.2006","journal-title":"Clin Vaccine Immunol"},{"key":"369_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00253-017-8535-7","volume":"102","author":"K Goderska","year":"2018","unstructured":"Goderska K, Agudo Pena S, Alarcon T (2018) Helicobacter pylori treatment: antibiotics or probiotics. Appl Microbiol Biotechnol 102:1\u20137. https:\/\/doi.org\/10.1007\/s00253-017-8535-7","journal-title":"Appl Microbiol Biotechnol"},{"key":"369_CR13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506\u2013514. https:\/\/doi.org\/10.1038\/nrgastro.2014.66","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"369_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002753","volume":"3","author":"C Hoarau","year":"2008","unstructured":"Hoarau C, Martin L, Faugaret D, Baron C, Dauba A, Aubert-Jacauin C, Velge-Roussel F, Lebranchu Y (2008) Supernatant from Bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells. PLoS One 3:e2753. https:\/\/doi.org\/10.1371\/journal.pone.0002753","journal-title":"PLoS One"},{"key":"369_CR15","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3748\/wjg.15.1119","volume":"15","author":"M Jarosz","year":"2009","unstructured":"Jarosz M, Rychlik E, Siuba M, REspondek W, Ryzko-Skiba M, Sajor I, Gugala S, Blazejczyk T, Ciok J (2009) Dietary and socio-economic factors in relation to Helicobacter pylori re-infection. World J Gastroenterol 15:1119\u20131125","journal-title":"World J Gastroenterol"},{"key":"369_CR16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1023\/B:DDAS.0000037794.02040.c2","volume":"49","author":"KC Johnson-Henry","year":"2004","unstructured":"Johnson-Henry KC, Mitchell DJ, Avitzur Y, Galindo-Mata E, Jones NL, Sherman PM (2004) Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig Dis Sci 49:1095\u20131102","journal-title":"Dig Dis Sci"},{"key":"369_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.5009\/gnl17177","volume":"12","author":"JH Jung","year":"2018","unstructured":"Jung JH, Cho IK, Lee CH, Song GG, Lim JH (2018) Clinical outcomes of standard triple therapy plus probiotics or concomitant therapy for Helicobacter pylori infection. Gut Liver 12:165\u2013172. https:\/\/doi.org\/10.5009\/gnl17177","journal-title":"Gut Liver"},{"key":"369_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/gut.41.1.49","volume":"41","author":"AM Kabir","year":"1997","unstructured":"Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y (1997) Prevention of Helicobacter pylori by lactobacilli in a gnotobiotic murine model. Gut 41:49\u201355","journal-title":"Gut"},{"key":"369_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5217\/ir.2011.9.3.171","volume":"9","author":"S Kamiya","year":"2011","unstructured":"Kamiya S (2011) Effect of probiotics on intestinal infections. Intestinal Res 9:171\u2013178","journal-title":"Intestinal Res"},{"key":"369_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/labinvest.2008.16","volume":"88","author":"JM Kim","year":"2008","unstructured":"Kim JM, Kim JS, Kim YJ, Oh YK, Kim IY, Chee YJ, Han JS, Jung HC (2008a) Conjugated linoleic acids produced by Lactobacillus dissociates IKK-\u03b3 and Hsp90 complex in Helicobacter pylori-infected gastric epithelial cells. Lab Investig 88:541\u2013552. https:\/\/doi.org\/10.1038\/labinvest.2008.16","journal-title":"Lab Investig"},{"key":"369_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1523-5378.2008.00601.x","volume":"13","author":"MN Kim","year":"2008","unstructured":"Kim MN, Kim N, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC, Song IS (2008b) The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter 13:261\u2013268. https:\/\/doi.org\/10.1111\/j.1523-5378.2008.00601.x","journal-title":"Helicobacter"},{"issue":"3","key":"369_CR22","doi-asserted-by":"publisher","first-page":"812S","DOI":"10.1093\/jn\/137.3.812S","volume":"137","author":"Drahoslava Lesbros-Pantoflickova","year":"2007","unstructured":"Lesbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL (2007) Helicobacter pylori and probiotics. J Nutr 137(Suppl 2):S812\u2013S818. https:\/\/doi.org\/10.1093\/jn\/137.3.812S","journal-title":"The Journal of Nutrition"},{"key":"369_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1750-3841.2009.01194.x","volume":"74","author":"WH Lin","year":"2009","unstructured":"Lin WH, Lin CK, Sheu SJ, Hwang CF, Ye WT, Hwang WZ, Tsen HY (2009) Antagonistic activity of spent culture supernatants of lactic acid bacteria against Helicobacter pylori growth and infection in human gastric epithelial AGS cells. J Food Sci 74:225\u2013230. https:\/\/doi.org\/10.1111\/j.1750-3841.2009.01194.x","journal-title":"J Food Sci"},{"key":"369_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1083-4389.2004.00214.x","volume":"9","author":"M Linsalata","year":"2004","unstructured":"Linsalata M, Russo F, Berloco P, Caruso ML, Matteo GD, Cifone MG, Simone CD, Ierardi E, Di Leo A (2004) The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 9:165\u2013172. https:\/\/doi.org\/10.1111\/j.1083-4389.2004.00214.x","journal-title":"Helicobacter"},{"key":"369_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jac\/dkm404","volume":"61","author":"M Lopez-Brea","year":"2008","unstructured":"Lopez-Brea M, Alarcon T, Domingo D, Diaz-Reganon J (2008) Inhibitory effect of gram-negative and gram-positive microorganisms against Helicobacter pylori. J Antimicrob Chemother 61:139\u2013142. https:\/\/doi.org\/10.1093\/jac\/dkm404","journal-title":"J Antimicrob Chemother"},{"key":"369_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3748\/wjg.v24.i1.139","volume":"24","author":"G Losurdo","year":"2018","unstructured":"Losurdo G, Cubisino R, Barone M, Principi M, Leandro G, Ierardi E, Di Leo A (2018) Probiotic monotherapy and Helicobacter pylori eradication: a systemic review with pooled-data analysis. World J Gastroenterol 24:139\u2013149. https:\/\/doi.org\/10.3748\/wjg.v24.i1.139","journal-title":"World J Gastroenterol"},{"key":"369_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep23522","volume":"6","author":"C Lu","year":"2016","unstructured":"Lu C, Sang J, He H, Wan X, Lin Y, Li L, Li Y, Yu C (2016) Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis. Sci Rep 6:23522\/DOI 10.1038. https:\/\/doi.org\/10.1038\/srep23522","journal-title":"Sci Rep"},{"issue":"10","key":"369_CR28","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1371\/journal.pone.0163743","volume":"11","author":"M L\u00fc","year":"2016","unstructured":"L\u00fc M, Yu S, Deng J, Yan Q, Yang C, Xia G, Zhou X (2016) Efficacy of probiotic supplementation therapy for Helicobacter pylori eradication: a meta-analysis of randomized controlled trials. PLoS One 11(10):1371. https:\/\/doi.org\/10.1371\/journal.pone.0163743","journal-title":"PLoS One"},{"key":"369_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","volume":"66","author":"P Malferltheiner","year":"2017","unstructured":"Malferltheiner P, Megraud F, O\u2019Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM, on behalf of the European Helicobacter and Microbiota Study Group and Consensus panel (2017) Management of Helicobacter pylori infection \u2013 the Maastrich V\/Florence Consensus Report. Gut 66:6\u201330. https:\/\/doi.org\/10.1136\/gutjnl-2016-312288","journal-title":"Gut"},{"key":"369_CR30","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/2050640615617358","volume":"4","author":"LV McFarland","year":"2016","unstructured":"McFarland LV, Huang Y, Wang L, Malfertheiner P (2016) Systematic review and meta-analysis: multi-strain probiotics as a adjunct therapy for Helicobacter pylori eradication and prevention of adverse effects. United European Gastroenterol J 4:546\u2013561. https:\/\/doi.org\/10.1177\/2050640615617358","journal-title":"United European Gastroenterol J"},{"key":"369_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000007660","volume":"60","author":"P Michetti","year":"1999","unstructured":"Michetti P, Dorta G, Wiesel H, Brassart D, Verdu E, Herranz M, Felley C, Porta N, Rouvet M, Blum AL, Corthesy-Theulaz I (1999) Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 60:203\u2013209. https:\/\/doi.org\/10.1159\/000007660","journal-title":"Digestion"},{"key":"369_CR32","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1128\/AEM.68.9.4642-4645.2002","volume":"68","author":"H Nam","year":"2002","unstructured":"Nam H, Ha M, Bae O, Lee Y (2002) Effect of Weissella confusa strain PL9001 on the adherence and growth of Hellicobacter pylori. Appl Environ Microbiol 68:4642\u20134645","journal-title":"Appl Environ Microbiol"},{"key":"369_CR33","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1365-2036.2004.02274.x","volume":"20","author":"EC Nista","year":"2004","unstructured":"Nista EC, Candelli M, Cremonini F, Cazzato IA, Zocco MA, Franceschi F, Cammarota G, Gasbarrini G, Gasbarrini A (2004) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: ranmdomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 20:1181\u20131188. https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02274.x","journal-title":"Aliment Pharmacol Ther"},{"key":"369_CR34","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1007\/s13197-015-1921-1","volume":"52","author":"KR Pandey","year":"2015","unstructured":"Pandey KR, Naik SR, Vakil BV (2015) Probiotics, prebiotics and synbiotics \u2013 a review. J Food Sci Technol 52:7577\u20137587. https:\/\/doi.org\/10.1007\/s13197-015-1921-1","journal-title":"J Food Sci Technol"},{"key":"369_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/clinids\/18.2.207","volume":"18","author":"R Patel","year":"1994","unstructured":"Patel R, Cockerill FR, Porayko MK, Osmon DR, Ilstrup DR, Keating MR (1994) Lactobacillemia in liver transplant patients. Clin Infect Dis 18:207\u2013212","journal-title":"Clin Infect Dis"},{"key":"369_CR36","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1128\/AAC.45.11.3156-3161.2001","volume":"45","author":"IV Pinchuk","year":"2001","unstructured":"Pinchuk IV, Bressollier P, Verneuil B, Fenet B, Sorokulova IB, Megraud F, Urdaci MC (2001) In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother 45:3156\u20133161. https:\/\/doi.org\/10.1128\/AAC.45.11.3156-3161.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"369_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00005176-199507000-00022","volume":"21","author":"M Pletincx","year":"1995","unstructured":"Pletincx M, Legein J, Vandenplas Y (1995) Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea. J Pediatr Gastroenterol Nutr 21:113\u2013115","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"369_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.phrs.2010.01.004","volume":"61","author":"EM Quigley","year":"2010","unstructured":"Quigley EM (2010) Prebiotics and probiotics: modifying and mining the microbiota. Pharmacol Res 61:213\u2013218. https:\/\/doi.org\/10.1016\/j.phrs.2010.01.004","journal-title":"Pharmacol Res"},{"key":"369_CR39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2174\/187152812800392698","volume":"11","author":"R Rosania","year":"2012","unstructured":"Rosania R, Minenna MF, Giorgio F, Facciorusso A, De Francesco V, Hassan C, Panella C, Ierardi E (2012) Probiotic multistrain treatment may eradicate Helicobacter pylori from the stomach of dyspeptics; a placebo-controlled pilot study. Inflamm Allergy Drug Targets 11:244\u2013249","journal-title":"Inflamm Allergy Drug Targets"},{"key":"369_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jac\/47.5.709","volume":"47","author":"I Sakamoto","year":"2001","unstructured":"Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y (2001) Suppresive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 47:709\u2013710","journal-title":"J Antimicrob Chemother"},{"key":"369_CR41","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1128\/AEM.70.1.518-526.2004","volume":"70","author":"D Sgouras","year":"2004","unstructured":"Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A (2004) In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei Shirota. Appl Environ Microbiol 70:518\u2013526","journal-title":"Appl Environ Microbiol"},{"key":"369_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/MEG.0b013e32830d0eff","volume":"21","author":"A Sachdeva","year":"2009","unstructured":"Sachdeva A, Nagpal J (2009) Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systemic review and meta-analysis of randomized-controlled trials. Eur J Gatrotenterol Hepatol 21:45\u201353. https:\/\/doi.org\/10.1097\/MEG.0b013e32830d0eff","journal-title":"Eur J Gatrotenterol Hepatol"},{"key":"369_CR43","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1046\/j.1365-2036.2002.01335.x","volume":"16","author":"BS Sheu","year":"2002","unstructured":"Sheu BS, Wu JJ, Lo CY, Wu HW, Chen JH, Lin YS, Lin MD (2002) Impact of supplement with Lactobacillus- and Bifidobacterium containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 16:1669\u20131675","journal-title":"Aliment Pharmacol Ther"},{"key":"369_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5005\/jp-journals-10018-1205","volume":"7","author":"BN Sirvan","year":"2017","unstructured":"Sirvan BN, Usta MK, Kizikan NU, Urganci N (2017) Are synbiotics added to the standard therapy to eradicate Helicobacter pylori in children beneficial? A randomized controlled study. Eur J Hepatogastroenterol 7:17\u201322. https:\/\/doi.org\/10.5005\/jp-journals-10018-1205","journal-title":"Eur J Hepatogastroenterol"},{"key":"369_CR45","first-page":"53","volume":"1","author":"GW Tannock","year":"1999","unstructured":"Tannock GW (1999) Identification of lactobacilli and bifidobacteria. Curr Issues Mol Biol 1:53\u201364","journal-title":"Curr Issues Mol Biol"},{"key":"369_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1099\/0022-1317-49-7-635","volume":"49","author":"M Takahashi","year":"2000","unstructured":"Takahashi M, Taguchi H, Yamaguchi H, Osaki T, Kamiya S (2000) Studies of the effect of Clostridium butyricum on Helicobacter pylori in several test models including gnotobiotic mice. J Med Microbiol 49:635\u2013642. https:\/\/doi.org\/10.1099\/0022-1317-49-7-635","journal-title":"J Med Microbiol"},{"issue":"1","key":"369_CR47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12602-018-9385-z","volume":"11","author":"Sujitra Techo","year":"2018","unstructured":"Techo S, Visseanguan W, Vilaichone R-k, Tanasupawat S (2018) Characterization and antibacterial activity against Helicobacter pylori of lactic acid bacteria isolated from Thai fermented rice noodle. Probiotics Antimicrob Proteins. https:\/\/doi.org\/10.1007\/s12602-018-9385-z","journal-title":"Probiotics and Antimicrobial Proteins"},{"key":"369_CR48","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1542\/peds.2010-2548","volume":"126","author":"DW Thomas","year":"2010","unstructured":"Thomas DW, Greer FR, American Academy of Pediatrics Committee on Nutrition, American Academy of Pediatrics Section on Gastroenterology, Hepatology and Nutrition (2010) Probiotics and prebiotics in pediatrics. Pediatrics 126:1217\u20131231. https:\/\/doi.org\/10.1542\/peds.2010-2548","journal-title":"Pediatrics"},{"key":"369_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2036.2006.03179.x","volume":"25","author":"JL Tong","year":"2007","unstructured":"Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD (2007) Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 25:155\u2013168. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.03179.x","journal-title":"Aliment Pharmacol Ther"},{"key":"369_CR50","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12602-017-9342-2","volume":"10","author":"VH Urrutia-Beca","year":"2018","unstructured":"Urrutia-Beca VH, Escamilla-Garcia E, de la Garza-Ramos MA, Tamez-Guerra P, Gomez-Flores R, Urbina-Rios CS (2018) In vitro antimicrobial activity and downregulation of virulence gene expression on Helicobacter pylori by reuterin. Probiotics Antimicrob Proteins 10:168\u2013175. https:\/\/doi.org\/10.1007\/s12602-017-9342-2","journal-title":"Probiotics Antimicrob Proteins"},{"key":"369_CR51","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.clinre.2017.04.004","volume":"41","author":"F Wang","year":"2017","unstructured":"Wang F, Feng J, Chen P, Liu X, Ma M, Zhou R, Chang Y, Liu J, Li J, Zhao Q (2017) Probiotics in Helicobacter pylori eradication therapy: systemic review and network meta-analysis. Clin Res Hepatol Gastroenterol 41:466\u2013475. https:\/\/doi.org\/10.1016\/j.clinre.2017.04.004","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"369_CR52","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/ajcn\/80.3.737","volume":"80","author":"KY Wang","year":"2004","unstructured":"Wang KY, Li SN, Liu CS, Perng DS, Su YC, Wu DC, Jan CM, Lai CH, Wang TN, Wang WM (2004) Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 80:737\u2013741. https:\/\/doi.org\/10.1093\/ajcn\/80.3.737","journal-title":"Am J Clin Nutr"},{"key":"369_CR53","doi-asserted-by":"publisher","first-page":"96406","DOI":"10.18632\/oncotarget.21633","volume":"8","author":"J Wen","year":"2017","unstructured":"Wen J, Peng P, Chen P, Zeng L, Pan Q, Wei W, He J (2017) Probiotics in 14-day triple therapy for Asian pediatric patients with Helicobacter pylori infection: a network meta-analysis. Oncotarget 8:96406\u201396418. https:\/\/doi.org\/10.18632\/oncotarget.21633","journal-title":"Oncotarget"},{"key":"369_CR54","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.dld.2015.06.010","volume":"47","author":"RM Zagari","year":"2015","unstructured":"Zagari RM, Ramano M, Ojetti SR, Gullini S, Annibale B, Farianti F, Ieraudi E, Maconi G, Rugge M, Calabrese C, Di Mario F, Luzza F, Pretolani S, Savio A, Gasbarrini G, Caselli M (2015) Guidelines for the management of Helicobacter pylori infection in Italy: the III Working Group Consensus Report 2015. Dig Liv Dis 47:903\u2013912. https:\/\/doi.org\/10.1016\/j.dld.2015.06.010","journal-title":"Dig Liv Dis"},{"key":"369_CR55","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jbiosc2018.04.003","volume":"126","author":"K Zhao","year":"2018","unstructured":"Zhao K, Xie Q, Xu D, Guo Y, Tao X, Wei H, Wan C (2018) Antagonistics of Lactobacillus plantarum ZDY2013 against Helicobacter pylori SS1 and its infection in vitro in human gastric epithelial AGS cells. J Biosci Bioeng 126:458\u2013463. https:\/\/doi.org\/10.1016\/j.jbiosc2018.04.003","journal-title":"J Biosci Bioeng"},{"key":"369_CR56","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.3748\/wjg.14.5090","volume":"14","author":"C Zhou","year":"2008","unstructured":"Zhou C, Ma FZ, Deng XJ, Yuan H, Ma HS (2008) Lactobacillus inhibit interleukin-8 production induced by Helicobacter pylori. World J Gastroenterol 14:5090\u20135095","journal-title":"World J Gastroenterol"}],"container-title":["Advances in Experimental Medicine and Biology","Helicobacter pylori in Human Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2019_369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T01:15:35Z","timestamp":1582938935000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/5584_2019_369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030219154","9783030219161"],"references-count":56,"URL":"https:\/\/doi.org\/10.1007\/5584_2019_369","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"24 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}